|
Topics in Evidence-Based Pharmacy Practice
9/28/2010: Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events
Clarissa Mauricio
Feik School of Pharmacy, University of the Incarnate Word, San Antonio, Texas
Joshua Fugate
Feik School of Pharmacy, University of the Incarnate Word, San Antonio, Texas
Amy P. Witte
Feik School of Pharmacy, University of the Incarnate Word, San Antonio, Texas
Excerpt:"Diabetes, and its subsequent cardiovascular (CV) complications, is a growing epidemic in the United States. Some studies have shown that inhibition of the renin-angiotensin aldosterone system (RAAS) by the use of angiotensin receptor blockers (ARBs) may reduce the risk of diabetes and cardiovascular complications. However, most of the trials to date have not studied incidence of diabetes as a primary outcome.1 ..."
|
|
|
|
|